11cancer
Multiparametric MRI Shows Promise in Breast Cancer Subtyping
Multiparametric MRI Shows Promise in Breast Cancer Subtyping EMJ
Global Cancer Cases Could Surge 67% by 2050, New Report Warns
Global Cancer Cases Could Surge 67% by 2050, New Report Warns SciTechDailyCancer to affect 92% of world’s population in some way: Report Down To EarthHealth matters newsletter…
WHO calls for urgent intervention on cancer
WHO calls for urgent intervention on cancer BusinessLineWHO calls for urgent action as new cancer cases are projected to nearly double by 2050 World Health Organization (WHO)Cancer…
26,000 daily deaths: Oncologist explains top 5 reasons behind fast spread of cancer
26,000 daily deaths: Oncologist explains top 5 reasons behind fast spread of cancer Moneycontrol.comWHO calls for urgent action as new cancer cases are projected to nearly…
Cancer in India: WHO Report Reveals 1 in 10 Indians at Risk before Age 75
Cancer in India: WHO Report Reveals 1 in 10 Indians at Risk before Age 75 Sanskriti IASCancer to affect 92% of world’s population in some way:…
WHO Calls for Urgent Global Action as Cancer Cases Expected to Nearly Double by 2050
WHO Calls for Urgent Global Action as Cancer Cases Expected to Nearly Double by 2050 fundsforNGOs NewsCancer burden is nearly universal, yet highly inequitable in its…
Colon Cancer Cells Change Identity To Drive Tumour Spread: Study
Colon Cancer Cells Change Identity To Drive Tumour Spread: Study NDTVStudy unveils how colon cancer cells change identity to spread ET HealthWorldOrganoids unveil key role of transcription…
Gastric Cancer Risk Score Validated in UK Biobank
Gastric Cancer Risk Score Validated in UK Biobank European Medical Journal
AIIMS-trained gastroenterologist shares 7 silent signs of pancreatic cancer: Sudden diabetes, weight loss, and more | Health
AIIMS-trained gastroenterologist shares 7 silent signs of pancreatic cancer: Sudden diabetes, weight loss, and more | Health Hindustan TimesThe Cancer Search Bar: Top Pancreatic Cancer Questions…
How Are New Therapies Reshaping the HER2+ Breast Cancer Landscape?
How Are New Therapies Reshaping the HER2+ Breast Cancer Landscape? MedscapeT-DXd Plus Pertuzumab Sets New Treatment and Research Standards in HER2+ Breast Cancer OncLive
- 1
- 2